CD19 Repopulation and Anti-phospholipase A2 Receptor (PLA2R) following Rituximab in Membranous Nephropathy
Journal of the American Society of Nephrology · 2024-10 · 35 (10S)
DOI: 10.1681/asn.20249xmhqcw6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, 2024-10. Verfasst von Durga Anil K Kanigicherla und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kanigicherla, D. A. K., Hamilton, P., Shukkur, M. M., Thet, M. K., & Ragy, O. S. (2024). CD19 Repopulation and Anti-phospholipase A2 Receptor (PLA2R) following Rituximab in Membranous Nephropathy. Journal of the American Society of Nephrology, 35(10S). https://doi.org/10.1681/asn.20249xmhqcw6
Vancouver
Kanigicherla DAK, Hamilton P, Shukkur MM, Thet MK, Ragy OS. CD19 Repopulation and Anti-phospholipase A2 Receptor (PLA2R) following Rituximab in Membranous Nephropathy. Journal of the American Society of Nephrology. 2024;35(10S). doi:10.1681/asn.20249xmhqcw6
BibTeX
@article{Kanigicherla2024,
author = {Kanigicherla, Durga Anil K and Hamilton, Patrick and Shukkur, Meshaal Mohemed and Thet, May Kyaw and Ragy, Omar Sherin},
title = {CD19 Repopulation and Anti-phospholipase A2 Receptor (PLA2R) following Rituximab in Membranous Nephropathy},
journal = {Journal of the American Society of Nephrology},
year = {2024},
volume = {35},
number = {10S},
doi = {10.1681/asn.20249xmhqcw6}
}
EUVIMED